nodes	percent_of_prediction	percent_of_DWPC	metapath
Felbamate—CYP2C19—Sorafenib—thyroid cancer	0.0477	0.388	CbGbCtD
Felbamate—CYP3A4—Vandetanib—thyroid cancer	0.0383	0.311	CbGbCtD
Felbamate—CYP3A4—Sorafenib—thyroid cancer	0.0231	0.187	CbGbCtD
Felbamate—CYP3A4—Doxorubicin—thyroid cancer	0.014	0.114	CbGbCtD
Felbamate—Lymphadenopathy—Epirubicin—thyroid cancer	0.00141	0.00161	CcSEcCtD
Felbamate—Nausea—Vandetanib—thyroid cancer	0.00141	0.00161	CcSEcCtD
Felbamate—Dyspepsia—Sorafenib—thyroid cancer	0.00141	0.00161	CcSEcCtD
Felbamate—Coma—Doxorubicin—thyroid cancer	0.0014	0.0016	CcSEcCtD
Felbamate—Oesophagitis—Doxorubicin—thyroid cancer	0.0014	0.0016	CcSEcCtD
Felbamate—Decreased appetite—Sorafenib—thyroid cancer	0.00139	0.00159	CcSEcCtD
Felbamate—Thrombophlebitis—Epirubicin—thyroid cancer	0.00139	0.00159	CcSEcCtD
Felbamate—Mouth ulceration—Doxorubicin—thyroid cancer	0.00139	0.00158	CcSEcCtD
Felbamate—Neoplasm—Doxorubicin—thyroid cancer	0.00139	0.00158	CcSEcCtD
Felbamate—Blood alkaline phosphatase increased—Epirubicin—thyroid cancer	0.00139	0.00158	CcSEcCtD
Felbamate—Fatigue—Sorafenib—thyroid cancer	0.00138	0.00158	CcSEcCtD
Felbamate—Pain—Sorafenib—thyroid cancer	0.00137	0.00156	CcSEcCtD
Felbamate—Constipation—Sorafenib—thyroid cancer	0.00137	0.00156	CcSEcCtD
Felbamate—Vascular purpura—Epirubicin—thyroid cancer	0.00135	0.00154	CcSEcCtD
Felbamate—Hepatic failure—Epirubicin—thyroid cancer	0.00134	0.00153	CcSEcCtD
Felbamate—Abnormal vision—Doxorubicin—thyroid cancer	0.00134	0.00153	CcSEcCtD
Felbamate—Mental disability—Doxorubicin—thyroid cancer	0.00133	0.00152	CcSEcCtD
Felbamate—Sepsis—Doxorubicin—thyroid cancer	0.00133	0.00152	CcSEcCtD
Felbamate—Gastrointestinal pain—Sorafenib—thyroid cancer	0.00131	0.00149	CcSEcCtD
Felbamate—Lymphadenopathy—Doxorubicin—thyroid cancer	0.00131	0.00149	CcSEcCtD
Felbamate—Renal failure acute—Epirubicin—thyroid cancer	0.00131	0.00149	CcSEcCtD
Felbamate—Thrombophlebitis—Doxorubicin—thyroid cancer	0.00129	0.00147	CcSEcCtD
Felbamate—Increased appetite—Epirubicin—thyroid cancer	0.00128	0.00146	CcSEcCtD
Felbamate—Blood alkaline phosphatase increased—Doxorubicin—thyroid cancer	0.00128	0.00146	CcSEcCtD
Felbamate—Urticaria—Sorafenib—thyroid cancer	0.00127	0.00145	CcSEcCtD
Felbamate—Abdominal pain—Sorafenib—thyroid cancer	0.00127	0.00145	CcSEcCtD
Felbamate—Body temperature increased—Sorafenib—thyroid cancer	0.00127	0.00145	CcSEcCtD
Felbamate—Renal impairment—Epirubicin—thyroid cancer	0.00127	0.00144	CcSEcCtD
Felbamate—Dermatitis bullous—Epirubicin—thyroid cancer	0.00126	0.00144	CcSEcCtD
Felbamate—Purpura—Epirubicin—thyroid cancer	0.00125	0.00143	CcSEcCtD
Felbamate—Vascular purpura—Doxorubicin—thyroid cancer	0.00125	0.00142	CcSEcCtD
Felbamate—Anaphylactoid reaction—Epirubicin—thyroid cancer	0.00125	0.00142	CcSEcCtD
Felbamate—Hepatic failure—Doxorubicin—thyroid cancer	0.00124	0.00142	CcSEcCtD
Felbamate—Hypoglycaemia—Epirubicin—thyroid cancer	0.00124	0.00141	CcSEcCtD
Felbamate—Cardiac failure—Epirubicin—thyroid cancer	0.00124	0.00141	CcSEcCtD
Felbamate—Hyponatraemia—Epirubicin—thyroid cancer	0.00121	0.00138	CcSEcCtD
Felbamate—Renal failure acute—Doxorubicin—thyroid cancer	0.00121	0.00138	CcSEcCtD
Felbamate—Diplopia—Epirubicin—thyroid cancer	0.00121	0.00137	CcSEcCtD
Felbamate—Osteoarthritis—Epirubicin—thyroid cancer	0.00121	0.00137	CcSEcCtD
Felbamate—Increased appetite—Doxorubicin—thyroid cancer	0.00119	0.00135	CcSEcCtD
Felbamate—Affect lability—Epirubicin—thyroid cancer	0.00119	0.00135	CcSEcCtD
Felbamate—Migraine—Epirubicin—thyroid cancer	0.00119	0.00135	CcSEcCtD
Felbamate—Renal impairment—Doxorubicin—thyroid cancer	0.00117	0.00134	CcSEcCtD
Felbamate—Dermatitis bullous—Doxorubicin—thyroid cancer	0.00117	0.00133	CcSEcCtD
Felbamate—Face oedema—Epirubicin—thyroid cancer	0.00116	0.00133	CcSEcCtD
Felbamate—Purpura—Doxorubicin—thyroid cancer	0.00116	0.00132	CcSEcCtD
Felbamate—Anaphylactoid reaction—Doxorubicin—thyroid cancer	0.00115	0.00131	CcSEcCtD
Felbamate—Asthenia—Sorafenib—thyroid cancer	0.00115	0.00131	CcSEcCtD
Felbamate—Cardiac arrest—Epirubicin—thyroid cancer	0.00115	0.00131	CcSEcCtD
Felbamate—Cardiac failure—Doxorubicin—thyroid cancer	0.00114	0.0013	CcSEcCtD
Felbamate—Hypoglycaemia—Doxorubicin—thyroid cancer	0.00114	0.0013	CcSEcCtD
Felbamate—Mood swings—Epirubicin—thyroid cancer	0.00114	0.0013	CcSEcCtD
Felbamate—Pruritus—Sorafenib—thyroid cancer	0.00113	0.00129	CcSEcCtD
Felbamate—Ataxia—Epirubicin—thyroid cancer	0.00113	0.00129	CcSEcCtD
Felbamate—Dehydration—Epirubicin—thyroid cancer	0.00112	0.00128	CcSEcCtD
Felbamate—Hyponatraemia—Doxorubicin—thyroid cancer	0.00112	0.00128	CcSEcCtD
Felbamate—Diplopia—Doxorubicin—thyroid cancer	0.00112	0.00127	CcSEcCtD
Felbamate—Osteoarthritis—Doxorubicin—thyroid cancer	0.00112	0.00127	CcSEcCtD
Felbamate—Migraine—Doxorubicin—thyroid cancer	0.0011	0.00125	CcSEcCtD
Felbamate—Affect lability—Doxorubicin—thyroid cancer	0.0011	0.00125	CcSEcCtD
Felbamate—Hypokalaemia—Epirubicin—thyroid cancer	0.0011	0.00125	CcSEcCtD
Felbamate—Diarrhoea—Sorafenib—thyroid cancer	0.0011	0.00125	CcSEcCtD
Felbamate—Toxic epidermal necrolysis—Epirubicin—thyroid cancer	0.00109	0.00124	CcSEcCtD
Felbamate—Aspartate aminotransferase increased—Epirubicin—thyroid cancer	0.00109	0.00124	CcSEcCtD
Felbamate—Face oedema—Doxorubicin—thyroid cancer	0.00108	0.00123	CcSEcCtD
Felbamate—Gastritis—Epirubicin—thyroid cancer	0.00107	0.00122	CcSEcCtD
Felbamate—Alanine aminotransferase increased—Epirubicin—thyroid cancer	0.00106	0.00121	CcSEcCtD
Felbamate—Muscular weakness—Epirubicin—thyroid cancer	0.00106	0.00121	CcSEcCtD
Felbamate—Cardiac arrest—Doxorubicin—thyroid cancer	0.00106	0.00121	CcSEcCtD
Felbamate—Dizziness—Sorafenib—thyroid cancer	0.00106	0.00121	CcSEcCtD
Felbamate—Mood swings—Doxorubicin—thyroid cancer	0.00106	0.0012	CcSEcCtD
Felbamate—Ataxia—Doxorubicin—thyroid cancer	0.00105	0.0012	CcSEcCtD
Felbamate—Dysphagia—Epirubicin—thyroid cancer	0.00104	0.00119	CcSEcCtD
Felbamate—Asthma—Epirubicin—thyroid cancer	0.00104	0.00119	CcSEcCtD
Felbamate—Dehydration—Doxorubicin—thyroid cancer	0.00104	0.00118	CcSEcCtD
Felbamate—Eosinophilia—Epirubicin—thyroid cancer	0.00103	0.00118	CcSEcCtD
Felbamate—Pancreatitis—Epirubicin—thyroid cancer	0.00102	0.00116	CcSEcCtD
Felbamate—Vomiting—Sorafenib—thyroid cancer	0.00102	0.00116	CcSEcCtD
Felbamate—Hypokalaemia—Doxorubicin—thyroid cancer	0.00101	0.00116	CcSEcCtD
Felbamate—Rash—Sorafenib—thyroid cancer	0.00101	0.00115	CcSEcCtD
Felbamate—Dermatitis—Sorafenib—thyroid cancer	0.00101	0.00115	CcSEcCtD
Felbamate—Toxic epidermal necrolysis—Doxorubicin—thyroid cancer	0.001	0.00115	CcSEcCtD
Felbamate—Aspartate aminotransferase increased—Doxorubicin—thyroid cancer	0.001	0.00115	CcSEcCtD
Felbamate—Headache—Sorafenib—thyroid cancer	0.001	0.00115	CcSEcCtD
Felbamate—Pancytopenia—Epirubicin—thyroid cancer	0.000989	0.00113	CcSEcCtD
Felbamate—Gastritis—Doxorubicin—thyroid cancer	0.000987	0.00113	CcSEcCtD
Felbamate—Alanine aminotransferase increased—Doxorubicin—thyroid cancer	0.000984	0.00112	CcSEcCtD
Felbamate—Muscular weakness—Doxorubicin—thyroid cancer	0.000984	0.00112	CcSEcCtD
Felbamate—Dysuria—Epirubicin—thyroid cancer	0.000974	0.00111	CcSEcCtD
Felbamate—Upper respiratory tract infection—Epirubicin—thyroid cancer	0.000968	0.0011	CcSEcCtD
Felbamate—Dysphagia—Doxorubicin—thyroid cancer	0.000964	0.0011	CcSEcCtD
Felbamate—Asthma—Doxorubicin—thyroid cancer	0.000964	0.0011	CcSEcCtD
Felbamate—Eosinophilia—Doxorubicin—thyroid cancer	0.000954	0.00109	CcSEcCtD
Felbamate—Nausea—Sorafenib—thyroid cancer	0.000952	0.00109	CcSEcCtD
Felbamate—Photosensitivity reaction—Epirubicin—thyroid cancer	0.000951	0.00108	CcSEcCtD
Felbamate—Weight increased—Epirubicin—thyroid cancer	0.000948	0.00108	CcSEcCtD
Felbamate—Pancreatitis—Doxorubicin—thyroid cancer	0.000945	0.00108	CcSEcCtD
Felbamate—Weight decreased—Epirubicin—thyroid cancer	0.000942	0.00107	CcSEcCtD
Felbamate—Hyperglycaemia—Epirubicin—thyroid cancer	0.00094	0.00107	CcSEcCtD
Felbamate—Pneumonia—Epirubicin—thyroid cancer	0.000934	0.00107	CcSEcCtD
Felbamate—Stevens-Johnson syndrome—Epirubicin—thyroid cancer	0.000921	0.00105	CcSEcCtD
Felbamate—Pancytopenia—Doxorubicin—thyroid cancer	0.000915	0.00104	CcSEcCtD
Felbamate—Jaundice—Epirubicin—thyroid cancer	0.000905	0.00103	CcSEcCtD
Felbamate—Conjunctivitis—Epirubicin—thyroid cancer	0.000903	0.00103	CcSEcCtD
Felbamate—Urinary tract infection—Epirubicin—thyroid cancer	0.000903	0.00103	CcSEcCtD
Felbamate—Dysuria—Doxorubicin—thyroid cancer	0.000901	0.00103	CcSEcCtD
Felbamate—Upper respiratory tract infection—Doxorubicin—thyroid cancer	0.000896	0.00102	CcSEcCtD
Felbamate—Sweating—Epirubicin—thyroid cancer	0.00089	0.00102	CcSEcCtD
Felbamate—Haematuria—Epirubicin—thyroid cancer	0.000886	0.00101	CcSEcCtD
Felbamate—Photosensitivity reaction—Doxorubicin—thyroid cancer	0.00088	0.001	CcSEcCtD
Felbamate—Weight increased—Doxorubicin—thyroid cancer	0.000877	0.001	CcSEcCtD
Felbamate—Epistaxis—Epirubicin—thyroid cancer	0.000876	0.000999	CcSEcCtD
Felbamate—Weight decreased—Doxorubicin—thyroid cancer	0.000872	0.000994	CcSEcCtD
Felbamate—Sinusitis—Epirubicin—thyroid cancer	0.000871	0.000994	CcSEcCtD
Felbamate—Hyperglycaemia—Doxorubicin—thyroid cancer	0.000869	0.000992	CcSEcCtD
Felbamate—Agranulocytosis—Epirubicin—thyroid cancer	0.000867	0.000988	CcSEcCtD
Felbamate—Pneumonia—Doxorubicin—thyroid cancer	0.000864	0.000986	CcSEcCtD
Felbamate—Stevens-Johnson syndrome—Doxorubicin—thyroid cancer	0.000852	0.000972	CcSEcCtD
Felbamate—Bradycardia—Epirubicin—thyroid cancer	0.000849	0.000968	CcSEcCtD
Felbamate—Haemoglobin—Epirubicin—thyroid cancer	0.000838	0.000956	CcSEcCtD
Felbamate—Jaundice—Doxorubicin—thyroid cancer	0.000838	0.000955	CcSEcCtD
Felbamate—Rhinitis—Epirubicin—thyroid cancer	0.000836	0.000953	CcSEcCtD
Felbamate—Urinary tract infection—Doxorubicin—thyroid cancer	0.000835	0.000953	CcSEcCtD
Felbamate—Conjunctivitis—Doxorubicin—thyroid cancer	0.000835	0.000953	CcSEcCtD
Felbamate—Haemorrhage—Epirubicin—thyroid cancer	0.000834	0.000951	CcSEcCtD
Felbamate—Hepatitis—Epirubicin—thyroid cancer	0.000834	0.000951	CcSEcCtD
Felbamate—Pharyngitis—Epirubicin—thyroid cancer	0.000828	0.000944	CcSEcCtD
Felbamate—Sweating—Doxorubicin—thyroid cancer	0.000824	0.00094	CcSEcCtD
Felbamate—Haematuria—Doxorubicin—thyroid cancer	0.000819	0.000934	CcSEcCtD
Felbamate—Epistaxis—Doxorubicin—thyroid cancer	0.000811	0.000924	CcSEcCtD
Felbamate—Sinusitis—Doxorubicin—thyroid cancer	0.000806	0.000919	CcSEcCtD
Felbamate—Visual impairment—Epirubicin—thyroid cancer	0.000804	0.000916	CcSEcCtD
Felbamate—Agranulocytosis—Doxorubicin—thyroid cancer	0.000802	0.000915	CcSEcCtD
Felbamate—Erythema multiforme—Epirubicin—thyroid cancer	0.000788	0.000899	CcSEcCtD
Felbamate—Bradycardia—Doxorubicin—thyroid cancer	0.000785	0.000896	CcSEcCtD
Felbamate—Haemoglobin—Doxorubicin—thyroid cancer	0.000775	0.000884	CcSEcCtD
Felbamate—Flushing—Epirubicin—thyroid cancer	0.000774	0.000882	CcSEcCtD
Felbamate—Rhinitis—Doxorubicin—thyroid cancer	0.000773	0.000882	CcSEcCtD
Felbamate—Hepatitis—Doxorubicin—thyroid cancer	0.000771	0.00088	CcSEcCtD
Felbamate—Haemorrhage—Doxorubicin—thyroid cancer	0.000771	0.00088	CcSEcCtD
Felbamate—Pharyngitis—Doxorubicin—thyroid cancer	0.000766	0.000873	CcSEcCtD
Felbamate—Chills—Epirubicin—thyroid cancer	0.000748	0.000853	CcSEcCtD
Felbamate—Visual impairment—Doxorubicin—thyroid cancer	0.000743	0.000848	CcSEcCtD
Felbamate—Alopecia—Epirubicin—thyroid cancer	0.000737	0.00084	CcSEcCtD
Felbamate—Erythema multiforme—Doxorubicin—thyroid cancer	0.000729	0.000832	CcSEcCtD
Felbamate—Flushing—Doxorubicin—thyroid cancer	0.000716	0.000817	CcSEcCtD
Felbamate—Flatulence—Epirubicin—thyroid cancer	0.000715	0.000816	CcSEcCtD
Felbamate—Tension—Epirubicin—thyroid cancer	0.000712	0.000812	CcSEcCtD
Felbamate—Dysgeusia—Epirubicin—thyroid cancer	0.000711	0.000811	CcSEcCtD
Felbamate—Nervousness—Epirubicin—thyroid cancer	0.000705	0.000804	CcSEcCtD
Felbamate—Chills—Doxorubicin—thyroid cancer	0.000692	0.000789	CcSEcCtD
Felbamate—Alopecia—Doxorubicin—thyroid cancer	0.000682	0.000777	CcSEcCtD
Felbamate—Ill-defined disorder—Epirubicin—thyroid cancer	0.000673	0.000768	CcSEcCtD
Felbamate—Anaemia—Epirubicin—thyroid cancer	0.000671	0.000765	CcSEcCtD
Felbamate—Agitation—Epirubicin—thyroid cancer	0.000667	0.000761	CcSEcCtD
Felbamate—Flatulence—Doxorubicin—thyroid cancer	0.000662	0.000755	CcSEcCtD
Felbamate—Tension—Doxorubicin—thyroid cancer	0.000659	0.000752	CcSEcCtD
Felbamate—Dysgeusia—Doxorubicin—thyroid cancer	0.000658	0.00075	CcSEcCtD
Felbamate—Malaise—Epirubicin—thyroid cancer	0.000655	0.000746	CcSEcCtD
Felbamate—Nervousness—Doxorubicin—thyroid cancer	0.000652	0.000744	CcSEcCtD
Felbamate—Leukopenia—Epirubicin—thyroid cancer	0.00065	0.000741	CcSEcCtD
Felbamate—Palpitations—Epirubicin—thyroid cancer	0.000641	0.000731	CcSEcCtD
Felbamate—Cough—Epirubicin—thyroid cancer	0.000633	0.000722	CcSEcCtD
Felbamate—Hypertension—Epirubicin—thyroid cancer	0.000627	0.000715	CcSEcCtD
Felbamate—Ill-defined disorder—Doxorubicin—thyroid cancer	0.000623	0.000711	CcSEcCtD
Felbamate—Anaemia—Doxorubicin—thyroid cancer	0.000621	0.000708	CcSEcCtD
Felbamate—Myalgia—Epirubicin—thyroid cancer	0.000618	0.000705	CcSEcCtD
Felbamate—Chest pain—Epirubicin—thyroid cancer	0.000618	0.000705	CcSEcCtD
Felbamate—Arthralgia—Epirubicin—thyroid cancer	0.000618	0.000705	CcSEcCtD
Felbamate—Agitation—Doxorubicin—thyroid cancer	0.000617	0.000704	CcSEcCtD
Felbamate—Anxiety—Epirubicin—thyroid cancer	0.000616	0.000702	CcSEcCtD
Felbamate—Discomfort—Epirubicin—thyroid cancer	0.000611	0.000696	CcSEcCtD
Felbamate—Malaise—Doxorubicin—thyroid cancer	0.000606	0.000691	CcSEcCtD
Felbamate—Dry mouth—Epirubicin—thyroid cancer	0.000604	0.000689	CcSEcCtD
Felbamate—Leukopenia—Doxorubicin—thyroid cancer	0.000601	0.000686	CcSEcCtD
Felbamate—Confusional state—Epirubicin—thyroid cancer	0.000597	0.000681	CcSEcCtD
Felbamate—Palpitations—Doxorubicin—thyroid cancer	0.000593	0.000677	CcSEcCtD
Felbamate—Oedema—Epirubicin—thyroid cancer	0.000592	0.000676	CcSEcCtD
Felbamate—Anaphylactic shock—Epirubicin—thyroid cancer	0.000592	0.000676	CcSEcCtD
Felbamate—Infection—Epirubicin—thyroid cancer	0.000589	0.000671	CcSEcCtD
Felbamate—Cough—Doxorubicin—thyroid cancer	0.000586	0.000668	CcSEcCtD
Felbamate—Thrombocytopenia—Epirubicin—thyroid cancer	0.00058	0.000661	CcSEcCtD
Felbamate—Hypertension—Doxorubicin—thyroid cancer	0.00058	0.000661	CcSEcCtD
Felbamate—Tachycardia—Epirubicin—thyroid cancer	0.000578	0.000659	CcSEcCtD
Felbamate—Hyperhidrosis—Epirubicin—thyroid cancer	0.000573	0.000653	CcSEcCtD
Felbamate—Myalgia—Doxorubicin—thyroid cancer	0.000572	0.000652	CcSEcCtD
Felbamate—Arthralgia—Doxorubicin—thyroid cancer	0.000572	0.000652	CcSEcCtD
Felbamate—Chest pain—Doxorubicin—thyroid cancer	0.000572	0.000652	CcSEcCtD
Felbamate—Anxiety—Doxorubicin—thyroid cancer	0.00057	0.00065	CcSEcCtD
Felbamate—Discomfort—Doxorubicin—thyroid cancer	0.000565	0.000644	CcSEcCtD
Felbamate—Anorexia—Epirubicin—thyroid cancer	0.000565	0.000644	CcSEcCtD
Felbamate—Dry mouth—Doxorubicin—thyroid cancer	0.000559	0.000638	CcSEcCtD
Felbamate—Hypotension—Epirubicin—thyroid cancer	0.000554	0.000631	CcSEcCtD
Felbamate—Confusional state—Doxorubicin—thyroid cancer	0.000553	0.00063	CcSEcCtD
Felbamate—Anaphylactic shock—Doxorubicin—thyroid cancer	0.000548	0.000625	CcSEcCtD
Felbamate—Oedema—Doxorubicin—thyroid cancer	0.000548	0.000625	CcSEcCtD
Felbamate—Infection—Doxorubicin—thyroid cancer	0.000545	0.000621	CcSEcCtD
Felbamate—Musculoskeletal discomfort—Epirubicin—thyroid cancer	0.00054	0.000615	CcSEcCtD
Felbamate—Thrombocytopenia—Doxorubicin—thyroid cancer	0.000537	0.000612	CcSEcCtD
Felbamate—Insomnia—Epirubicin—thyroid cancer	0.000536	0.000611	CcSEcCtD
Felbamate—Tachycardia—Doxorubicin—thyroid cancer	0.000535	0.00061	CcSEcCtD
Felbamate—Paraesthesia—Epirubicin—thyroid cancer	0.000532	0.000607	CcSEcCtD
Felbamate—Hyperhidrosis—Doxorubicin—thyroid cancer	0.00053	0.000604	CcSEcCtD
Felbamate—Dyspnoea—Epirubicin—thyroid cancer	0.000528	0.000602	CcSEcCtD
Felbamate—Somnolence—Epirubicin—thyroid cancer	0.000527	0.000601	CcSEcCtD
Felbamate—Anorexia—Doxorubicin—thyroid cancer	0.000522	0.000596	CcSEcCtD
Felbamate—Dyspepsia—Epirubicin—thyroid cancer	0.000521	0.000595	CcSEcCtD
Felbamate—Decreased appetite—Epirubicin—thyroid cancer	0.000515	0.000587	CcSEcCtD
Felbamate—Hypotension—Doxorubicin—thyroid cancer	0.000512	0.000584	CcSEcCtD
Felbamate—Fatigue—Epirubicin—thyroid cancer	0.000511	0.000582	CcSEcCtD
Felbamate—Constipation—Epirubicin—thyroid cancer	0.000507	0.000578	CcSEcCtD
Felbamate—Pain—Epirubicin—thyroid cancer	0.000507	0.000578	CcSEcCtD
Felbamate—Musculoskeletal discomfort—Doxorubicin—thyroid cancer	0.000499	0.000569	CcSEcCtD
Felbamate—Insomnia—Doxorubicin—thyroid cancer	0.000496	0.000565	CcSEcCtD
Felbamate—Paraesthesia—Doxorubicin—thyroid cancer	0.000492	0.000561	CcSEcCtD
Felbamate—Dyspnoea—Doxorubicin—thyroid cancer	0.000489	0.000557	CcSEcCtD
Felbamate—Feeling abnormal—Epirubicin—thyroid cancer	0.000488	0.000557	CcSEcCtD
Felbamate—Somnolence—Doxorubicin—thyroid cancer	0.000487	0.000556	CcSEcCtD
Felbamate—Gastrointestinal pain—Epirubicin—thyroid cancer	0.000484	0.000552	CcSEcCtD
Felbamate—Dyspepsia—Doxorubicin—thyroid cancer	0.000482	0.00055	CcSEcCtD
Felbamate—Decreased appetite—Doxorubicin—thyroid cancer	0.000476	0.000543	CcSEcCtD
Felbamate—Fatigue—Doxorubicin—thyroid cancer	0.000473	0.000539	CcSEcCtD
Felbamate—Urticaria—Epirubicin—thyroid cancer	0.000471	0.000537	CcSEcCtD
Felbamate—Pain—Doxorubicin—thyroid cancer	0.000469	0.000535	CcSEcCtD
Felbamate—Constipation—Doxorubicin—thyroid cancer	0.000469	0.000535	CcSEcCtD
Felbamate—Abdominal pain—Epirubicin—thyroid cancer	0.000468	0.000534	CcSEcCtD
Felbamate—Body temperature increased—Epirubicin—thyroid cancer	0.000468	0.000534	CcSEcCtD
Felbamate—Feeling abnormal—Doxorubicin—thyroid cancer	0.000452	0.000515	CcSEcCtD
Felbamate—Gastrointestinal pain—Doxorubicin—thyroid cancer	0.000448	0.000511	CcSEcCtD
Felbamate—Urticaria—Doxorubicin—thyroid cancer	0.000435	0.000497	CcSEcCtD
Felbamate—Body temperature increased—Doxorubicin—thyroid cancer	0.000433	0.000494	CcSEcCtD
Felbamate—Abdominal pain—Doxorubicin—thyroid cancer	0.000433	0.000494	CcSEcCtD
Felbamate—Asthenia—Epirubicin—thyroid cancer	0.000425	0.000485	CcSEcCtD
Felbamate—Pruritus—Epirubicin—thyroid cancer	0.000419	0.000478	CcSEcCtD
Felbamate—Diarrhoea—Epirubicin—thyroid cancer	0.000405	0.000462	CcSEcCtD
Felbamate—Asthenia—Doxorubicin—thyroid cancer	0.000393	0.000448	CcSEcCtD
Felbamate—Dizziness—Epirubicin—thyroid cancer	0.000392	0.000447	CcSEcCtD
Felbamate—Pruritus—Doxorubicin—thyroid cancer	0.000388	0.000442	CcSEcCtD
Felbamate—Vomiting—Epirubicin—thyroid cancer	0.000377	0.00043	CcSEcCtD
Felbamate—Diarrhoea—Doxorubicin—thyroid cancer	0.000375	0.000428	CcSEcCtD
Felbamate—Rash—Epirubicin—thyroid cancer	0.000374	0.000426	CcSEcCtD
Felbamate—Dermatitis—Epirubicin—thyroid cancer	0.000373	0.000426	CcSEcCtD
Felbamate—Headache—Epirubicin—thyroid cancer	0.000371	0.000423	CcSEcCtD
Felbamate—Dizziness—Doxorubicin—thyroid cancer	0.000362	0.000413	CcSEcCtD
Felbamate—Nausea—Epirubicin—thyroid cancer	0.000352	0.000401	CcSEcCtD
Felbamate—Vomiting—Doxorubicin—thyroid cancer	0.000348	0.000397	CcSEcCtD
Felbamate—Rash—Doxorubicin—thyroid cancer	0.000346	0.000394	CcSEcCtD
Felbamate—Dermatitis—Doxorubicin—thyroid cancer	0.000345	0.000394	CcSEcCtD
Felbamate—Headache—Doxorubicin—thyroid cancer	0.000343	0.000392	CcSEcCtD
Felbamate—Nausea—Doxorubicin—thyroid cancer	0.000326	0.000371	CcSEcCtD
